(Q73094214)

English

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

scientific article published on 01 October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Claudio Gasperini

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

G Antonelli

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Simeoni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Bagnato

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Pozzilli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

O Turriziani

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Tesoro

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P Di Marco

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Fieschi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Dianzani

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

168

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

131-136

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Neutralising and binding anti-interferon-beta-I b (IFN-beta-I b) antibodies during IFN-beta-I b treatment of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Expression of human fibroblast interferon gene in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Site-specific mutagenesis of the human fibroblast interferon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Neutralizing antibodies to interferon beta-1a and interferon beta-1b in MS patients are cross-reactive

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Quantitation of neutralization of interferon by antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

The expression of potency of neutralizing antibodies for interferons and other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Correlation of the appearance of anti-interferon antibodies during treatment and dimunition of efficacy: summary of an International Workshop on Anti-Interferon Antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Human leukocyte interferon alpha: structure, pharmacology, and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900185-9

7 January 2021

Identifiers

10.1016/S0022-510X(99)00185-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526196%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73094214&oldid=1945275162"